Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Nature Reviews Drug Discovery 24 , 902-903 (2025) doi: Competing Interests The authors declare no competing interests.
Transparent prescribing practices : Sesame is not a pharmacy, which means that it has no financial incentive to prescribe one therapy over another
It is still in the Canadian CSP register, scheduled to take effect in March 2026 and last until March 2028
The American Diabetes Association (ADA) guidelines recognize GLP-1 receptor agonists as preferred agents for patients with type 2 diabetes who require additional glucose-lowering therapy beyond metformin, particularly those with established cardiovascular disease or chronic kidney disease, with preference given to agents with proven cardiovascular benefit
A Final Note & Gentle PSA on the GLP-1 Pipeline On the topic of GLP-1 misinformation, I'd like to share something from a webinar that really irked me, particularly in terms of the direction this GLP-1 marketing blitz is headed
US$ 23.01
US$ 28.43
US$ 20.69
US$ 28.14
US$ 29.10
:max_bytes(150000):strip_icc()/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)
US$ 25.21
